This content is from: Premium Hedge Fund Titans Bet Big on Drugmaker Shire’s Success John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux. By Bailey McCann December 08, 2016
This content is from: Research Pharmaceuticals & Health Care – Pharmaceuticals: Third February 05, 2013
This content is from: Portfolio Daily Agenda: Pessimism Reigns with Another Chinese Decline EU orders Belgium to collect unpaid corporate taxes; Shire-Baxalta merger to close; glam rocker David Bowie dead at 69. By Andrew Barber January 11, 2016
This content is from: Portfolio Daily Agenda: Scandals Rock Emerging Giants BTG Pactual CEO arrested in Brazil and another Chinese CEO goes missing; Shire to make a new bid for Baxalta; Russia turns off natural gas to Ukraine. By Andrew Barber November 25, 2015
This content is from: Research The 2015 All-Europe Research Team: Pharmaceuticals, No. 3: Mark Clark, Timothy Race & team The five-person Deutsche Bank team under the guidance of Mark Clark, 51, and Timothy Race, 41, slips from second place to third. February 18, 2015
This content is from: Corner Office John Paulson on Playing Today’s M&A Game The founder of Paulson & Co. has been doing merger arb for years. At Delivering Alpha he offers a tutorial on the current, booming M&A scene. By Robert Teitelman July 16, 2014
